Airja, Inc.

We are a team of experienced professionals with over 50 years of combined pharmaceutical and entrepreneurial successes. Airja has patented technology with a fundamentally different approach to respiratory drug delivery. Our mission is to bring confidence, safety, accuracy, and convenience to drug delivery. — Airja's new generation of respiratory drug delivery solutions — Pharmaceutical Technology: • Precise aerosol particle size control ensuring deep lung delivery and rapid pharmacokinetics. • Immediate treatment for indications such as pain, panic, migraine, insomnia. • Delivery of compounds currently only available as injections. • Simplified development of dose form, removes issues with dry powder (DPI’s) and metered dose inhalers (MDI’s). • Extends patent life for soon to come off patented compounds. Cannabinoid Vape Solution: • No wick, no leaking. • Reservoir isolated from the heater, protecting extract from thermal decomposition. • Microprocessor controlled pump. • Proprietary heating system. • Precise, reliable, and consistent dose. • 5x vapor production capability. • Flavor retention across the life of the cartridge. • Capability for micro-dosing and larger volumes of vapor. For licensing opportunities, investment, or joint development inquiries, please contact Beverly Connelly through email — b.connelly@airjatech.com